Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-14-020867)

Filing Details

Accession Number:: 0001104659-14-020867
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-03-19 12:20:25
Reporting Period:: 2014-03-18

Filing Date:: 2014-03-19
Accepted Time:: 2014-03-19 12:20:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1497504	Dipexium Pharmaceuticals Inc.	DPRX	Pharmaceutical Preparations (2834)	271707962

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1271123	P David Luci		President, Ceo, Secretary	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $.001 Per Share	Acquisiton	2014-03-18	2,083	$12.00	1,829,447	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $.001 Per Share	Employee Stock Option (right to buy)	Acquisiton	2014-03-18	298,826	$0.00	298,826	$13.93

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
298,826		2019-03-18	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $.001 Per Share	7,462	Indirect	By Spouse

Footnotes

Excludes 2,800 shares beneficially owned by family members of the Reporting Person, for which the Reporting Person maintains voting control but no pecuniary interest, and disclaims beneficial ownership therein.
The option vests in 36 equal monthly installments, with the first installment vesting on April 18, 2014.